HLA-B14 subtypes and their influence on allorecognition

Tissue Antigens

Volumn 47, Issue 3, 1996, Pages 253-256

  Gilman, A ^a,c   Auger, J J ^b   Terry, L ^a   Flomenberg, N ^a   Baxter Lowe, L A ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Alloreactivity; Bone marrow transplantation; HLA B14; Oligotyping

Indexed keywords

ALANINE; HLA B ANTIGEN; MONOCLONAL ANTIBODY; SERINE;

AMINO ACID SEQUENCE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA POLYMORPHISM; DNA SEQUENCE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; MONONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0029944457     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02550.x     Document Type: Article

References (26)

1. Parham P, Lawlor DA, Salter RD, Lomen CE, Bjorkman PJ, Ennis PD. HLA-A, B, C: patterns of polymorphism in peptide binding proteins. In: Dupont B, ed. Immunobiology of HLA Vol 2. New York: Springer-Verlag, 1989: 10.
2. Zemmour J, Parham P. HLA class I nucleotide sequences. Tissue Antigens 1991: 37: 174-180.
3. Anasetti C, Beatty PG, Storb R et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990: 29: 79-91.
4. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibilty on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989: 320: 197-204.
5. Keever CA, Leong N, Cunningham I et al. HLA-B44.2 directed cytotoxic T cells associated with acute graft vs. host disease following unrelated marrow transplantation. Bone Marrow Transplant 1994: 14: 137-145.
6. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 1990: 323: 1818-1822.
7. Parham P, Lomen CE, Lawlor DA et al. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci U S A 1988: 85: 4005-4009.
8. Domena JD, Azumi K, Bias WB, Parham P. B*1401 encodes the B64 antigen: the B64 and B65 splits of B14 differ only at residue 11, a buried amino acid. Tissue Antigens 1993: 41: 110-111.
9. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition regions of class 1 histocompatibility antigens. Nature 1987: 329: 512-518.
10. Kornbluth J, Silver DM, Dupont B. Cloning and characterization of primary alloreactive human T-lymphocytes. Immunol Rev 1981: 54: 111-155.
11. Schendel DJ, Wank R, Dupont B. Cell-mediated lympholysis: examination of HLA genetic fine structure and complementation using cytotoxic T lymphocytes. Eur J Immunol 1978: 8: 634-640.
12. Lechler RI, Lombardi G, Butchelor JR, Reinsmoen N, Bach FH. The molecular basis of reactivity. Immunol Today 1990: 11: 83.
13. Eckels DD. Alloreactivity: allogeneic presentation of endogenous peptide or direct recognition of MHC polymorphism? A review. Tissue Antigens 1990: 35: 49-55.
14. Levine JE, Yang SY. SSOP typing of the Tenth International Histocompatibility Workshop reference cell lines for HLA-C alleles. Tissue Antigens 1994: 44: 174-183.
15. Flomenberg N, Naito K, Duffy E, Knowles RW, Evans RL, Dupont B. Allocytotoxic T cell clones: both Leu 2+3- and Leu 2-3+ T cells recognize class I histocompatibility antigens. Eur J Immunol 1983: 13: 905-911.
16. Mueller-Eckhardt G, Schroeder ML, Darke C et al. Antigen Society #7 (B8, w59, B14, w64, w65). In: Dupont B, ed. Immunobiology of HLA Vol 1. New York: Springer-Verlag, 1989: 148-150.
17. Molkentin J, Gorski J, Baxter-Lowe LA. Detection of 14 HLA-DQB1 alleles by oligotyping. Hum Immunol 1991: 31: 114-122.
18. Yang SY, Milford E, Hammerling U, Dupont B. Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: the B-cell line panel designed for the Tenth International Histocompatibilty Workshop. In: Dupont B, ed. Immunobiology of HLA Vol 1. New York: Springer-Verlag, 1989: 11.
19. Bjorkman PJ, Saper MA, Samruoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987: 329: 506-512.
20. Garrett TPJ, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC. Specificity pockets for the side chains of peptide antigens of HLA-Aw68. Nature 1989: 342: 692-696.
21. Madden DR, Gorga JC, Strominger JL, Wiley DC. The three-dimensional structure of HLA-B27 at 2.1. A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 1992: 1035-1048.
22. Baur MP, Danilovs, JA. Population analysis of HLA-A,B,C,DR and other genetic markers. In: Terasaki PI, ed. Histocompatibility 1980. Los Angeles: UCLA Tissue Typing Laboratory, 1980: 955.
23. Kaminski E, Hows J, Man S et al. Prediction of graft-versus-host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation 1989: 48: 608-613.
24. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 1987: 43: 842-847.
25. Guttridge MG, Thompson J, Burr C, Darke C. The differentiation of HLA-B*1401 (B64) and B*1402 (B65) by the polymerase chain reaction using sequence-specific primers (PCR-SSP). Tissue Antigens 1995: 45: 213-215.
26. Gilman A, Auger J, Terry L, Flomenberg N, Baxter-Lowe LA. HLA-B14 subtypes and their influence on allorecognition. Hum Immunol 1992: 34: 23.